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Abstract 
Background: Ascorbic acid (AA) is a micronutrient essential for the mechanisms of reproduction, growth, and 
defense in fish. However, the biosynthesis of this micronutrient does not occur in fish, so it must be supplied with 
food. A difficulty is that plain AA is unstable, due to the effects of light, high temperature, and oxygen, among others. 
The use of nanoencapsulation may provide protection and preserve the physicochemical characteristics of AA for 
extended periods of time, decreasing losses due to environmental factors.
Method: This study evaluated the protective effect of nanoencapsulation in polymeric nanoparticles (chitosan and 
polycaprolactone) against AA degradation. Evaluation was made of the physicochemical stability of the nanoformula-
tions over time, as well as the toxicological effects in zebrafish (Danio rerio), considering behavior, development, and 
enzymatic activity. For the statistical tests, ANOVA (two-way, significance of p < 0.05) was used.
Results: Both nanoparticle formulations showed high encapsulation efficiency and good physicochemical stability 
during 90 days. Chitosan (CS) and polycaprolactone (PCL) nanoparticles loaded with AA had mean diameters of 314 
and 303 nm and polydispersity indexes of 0.36 and 0.28, respectively. Both nanosystems provided protection against 
degradation of AA exposed to an oxidizing agent, compared to plain AA. Total degradation of AA was observed after 
7, 20, and 480 min for plain AA, the CS nanoparticle formulation, and the PCL nanoparticle formulation, respectively. 
For zebrafish larvae, the  LC50 values were 330.7, 57.4, and 179.6 mg/L for plain AA, the CS nanoparticle formulation, 
and the PCL nanoparticle formulation, respectively. In toxicity assays using AA at a concentration of 50 mg/L, both 
types of nanoparticles loaded with AA showed lower toxicity towards the development of the zebrafish, compared 
to plain AA at the same concentration. Although decreased activity of the enzyme acetylcholinesterase (AChE) did 
not affect the swimming behavior of zebrafish larvae in the groups evaluated, it may have been associated with the 
observed morphometric changes, such as curvature of the tail.
Conclusions: This study showed that the use of nanosystems is promising for fish nutritional supplementation in 
aquaculture. In particular, PCL nanoparticles loaded with AA seemed to be most promising, due to higher protection 
against AA degradation, as well as lower toxicity to zebrafish, compared to the chitosan nanoparticles. The use of 
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Introduction
With the global population predicted to increase by 
approximately 30% to 9.7 billion in 2050, one of the great-
est challenges currently facing the world is food security 
[1]. Aquaculture can actively contribute to ensuring an 
adequate food supply, providing high quality protein to 
feed the growing world population, especially in devel-
oping countries [2]. However, in efforts to maximize 
production, the aquaculture sector faces challenges 
regarding the emergence of diseases, which are very com-
mon in intensive production systems [3]. Therefore, it is 
necessary to develop suitable strategies that can ensure 
the sustainable development of aquaculture [4]. The Blue 
Growth initiative aims at the sustainable global develop-
ment of aquaculture, enabling the sector to contribute to 
the Sustainable Development Goals (SDGs) of the United 
Nations, especially Goals 2 and 14. Goal 2 concerns the 
achievement of zero hunger, food security, and improved 
nutrition, while Goal 14 aims at the conservation and 
sustainable development of the oceans, seas, and marine 
resources [5, 6].
Among the strategies for the development of sustaina-
ble aquaculture, the utilization of natural sources of vita-
mins to improve the growth and development of aquatic 
species has been studied [2, 7, 8]. Vitamins act mainly as 
cofactors of enzymes, so their inadequate supplementa-
tion can be detrimental to organism growth and survival, 
with increased vulnerability to diseases and infections [9, 
10]. Due to their coenzyme activities, vitamins contribute 
to normal metabolic functioning and the maintenance of 
health [8]. The hydrophilic vitamin L-ascorbic acid (AA) 
is an essential micronutrient required by aquatic animals, 
since they do not have the ability to synthesize it [7, 8].
It has been reported that dietary supplementation with 
AA can positively affect growth performance, immuno-
logical responses, and survival rate, as well as increase 
the resistance to stressors in different fish species [8]. 
The amount of AA required in the diet varies according 
to species, size, age, breeding condition, and the form 
of AA administered [3]. In its pure form, ascorbic acid 
is unstable in alkaline environments, where its oxida-
tion is accelerated, leading to its loss at rates influenced 
by factors including temperature, oxygen, light, and pH, 
among others [11]. Therefore, it is important to develop 
new technologies capable of protecting this molecule 
against premature degradation, increasing its stability 
and bioavailability.
Nanoencapsulation offers a way to improve the stabil-
ity of AA [12, 13]. The materials used for nanoencapsula-
tion include a variety of matrices that may have natural 
or synthetic origins [14]. One such material, chitosan, is 
derived from chitin, obtained mainly from crustaceans 
such as crabs, although this polymer is also found in the 
cell walls of fungi. After being separated, chitin is submit-
ted to an alkalinization or acidification process. Chitosan 
easily penetrates cell and transcellular walls, is positively 
charged, forms complexes by hydrophobic interactions or 
hydrogen bonds, and is soluble in acidic media [15]. In 
fish, chitosan can adhere to the gills and skin, due to the 
interaction between chitosan nanoparticles and the layer 
of mucopolysaccharides and mucoproteins that covers 
the organism [16]. Other polymer widely used to nanoen-
capsulation is poly (ε-caprolactone), which is an aliphatic 
polyester, biodegradable and biocompatible. It is a FDA 
(US Food and Drug Administration) approved polymer 
with high permeability to many compounds, non-toxicity 
and reasonably low cost that renders this polymer attrac-
tiveness for aquaculture applications [17].
Despite the potential benefits of nanocarrier systems, 
concerns have been raised about the biosafety of their use 
in aquaculture. Therefore, it is necessary to evaluate and 
characterize the possible ecotoxicological risks result-
ing from their use, in order to make decisions about the 
implementation of these nanotechnologies in agricul-
tural practices [18]. Hence, it is essential to understand 
the potential effects of nanocarrier systems towards both 
target and nontarget organisms. For this purpose, the 
zebrafish (Danio rerio) has been used to assess the effects 
of different compounds on the fish community [19]. 
Monitoring of the development of Danio rerio provides 
a rapid way to evaluate the environmental risks of nano-
materials [20].
Decrease the premature degradation of AA, the aim 
of this work was to prepare and characterize polymeric 
nanoparticles (chitosan and polycaprolactone) used to 
encapsulate AA, followed by evaluation of their effects 
on the development of zebrafish embryos and larvae. In 
addition, nanoparticulate systems with or without AA 
were evaluated for possible toxic effects on the devel-
opment of these organisms. Different parameters of 
physical development were evaluated, including malfor-
mations, hatching and survival rates, and behavioral indi-
cators. The AchE activity was also determined, since its 
alteration can lead to impaired motor function [21]. This 
nanotechnology opens new perspectives for aquaculture, enabling the reduction of feed nutrient losses, leading to 
faster fish growth and improved sustainability of this activity.
Keywords: Chitosan nanoparticles, Polycaprolactone nanoparticles, Vitamin, Zebrafish, Ecotoxicity
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study opens perspectives for the development of systems 
for fish nutrition in aquaculture, aiming at more sustain-




L-ascorbic acid (99%), trehalose dihydrate, poly-ε-
caprolactone, and chitosan (50,000–190,000  Da) were 
obtained from Sigma-Aldrich and were used without 
further purification. Acetonitrile and methanol (HPLC 
grade) were obtained from J.T. Baker. Low molecular 
weight chitosan and the chemicals used in the oxidation 
assays (Oxone® and EDTA) were obtained from Sigma-
Aldrich. The AchE assays employed acetylthiocholine 




Nanoparticles composed of chitosan and sodium trip-
olyphosphate (TPP) were prepared by the ionic gelation 
technique at room temperature (25ºC), followed by spray 
drying, according to [22]. A 250 mL volume of an aqueous 
solution of acetic acid (0.5% v/v) was prepared contain-
ing low molecular weight chitosan (1% w/v). Separately, 
10  mL of an aqueous solution was prepared containing 
2.5 g of AA. The AA solution was added to the chitosan 
solution and the resulting mixture was homogenized for 
10 min, under magnetic stirring at 800 rpm. This solution 
was then dripped into 10  mL of TPP solution (1% w/v) 
under magnetic stirring at 800 rpm for 10 min. The final 
concentration of AA was 0.01 mg/mL. Control nanopar-
ticles were prepared using the same method described 
above, without addition of AA. In order to guarantee 
the nanoparticles dispersibility and their regular spheri-
cal shape, trehalose dihydrate (1% w/v) was used as addi-
tional excipient [23] The nanoparticles were dried using 
a laboratory spray dryer with a 1  mm diameter nozzle 
(Model MSD 1.0, Labmaq, Brazil). The operating condi-
tions were inlet temperature at 110.4 °C, outlet tempera-
ture at 72 °C, feed rate of 0.3 L  h−1, atomization flow of 
40 L  h−1, and drying flow of 1.50  m3  min−1. The powder 
obtained was stored at room temperature until use.
Polycaprolactone nanoparticles
Polycaprolactone nanoparticles were prepared by the 
double emulsion-evaporation method at room tem-
perature (25ºC), with slight modifications [24]. For the 
organic phase, 400  mg of PCL were dissolved in 20  mL 
of dichloromethane. The aqueous phase was PVA 
(3  mg   mL−1) dissolved in ultrapure water. AA was dis-
solved in ethanol and mixed with the aqueous phase 
containing PVA, followed by ultraturrax homogenization 
for 1 min at 14,000 rpm. The resulting mixture was added 
to the organic phase and homogenized for 8 min by ultra-
turrax at 14,000 rpm. The organic solvent was evaporated 
using a rotary evaporator and the formulation was con-
centrated to a volume of 10 mL. The final concentration 
of AA was 5  mg   mL−1. The nanoparticles were dried 
using a laboratory spray dryer with a 1 mm diameter noz-
zle (MSD 1.0, Labmaq, Brazil). In order to guarantee the 
nanoparticles re-dispersibility and their regular spherical 
shape, trehalose dihydrate (1%) was used as additional 
excipient [23]. The operating conditions were inlet tem-
perature at 110.4  °C, outlet temperature at 65.4  °C, feed 
rate of 0.3 L  h−1, atomization flow of 40 L  h−1, and drying 
flow of 1.50  m3   min−1. The powder obtained was stored 
at room temperature until use.
Nanoparticles characterization
Evaluation was made of the physicochemical charac-
teristics of both nanoparticle formulations, including 
the mean diameter, polydispersity index, zeta potential, 
pH, and encapsulation efficiency. For these analyses, the 
dried nanoparticles (10 mg) were resuspended in 1 mL of 
ultrapure water. The samples were stored in amber flasks 
at room temperature, protected from light.
Mean diameter and polydispersity index
The mean diameter and polydispersity index were deter-
mined by the photon correlation spectroscopy technique, 
using a ZetaSizer Nano ZS 90 instrument (Malvern 
Instruments) at an angle of 90°. The nanoparticle solu-
tions were diluted 1,500 times with deionized water. The 
measurements were performed in triplicate (n = 3).
Zeta potential and pH
The surface charges of the nanoparticles were deter-
mined by zeta potential measurements using the micro-
electrophoresis technique, employing a ZetaSizer Nano 
ZS 90 analyzer (Malvern Instruments). The samples were 
diluted 1,500 times and analyzed in triplicate. The pH 
values of the different formulations were obtained using 
a potentiometer (Tecnal) previously calibrated with pH 7 
and pH 4 standards.
Ascorbic acid (AA) encapsulation efficiency
The AA encapsulation efficiency was determined by the 
ultrafiltration-centrifugation method. The nanopar-
ticles were centrifuged using a 10  kDa cellulose filter 
(Millipore) that allowed the passage of non-encapsu-
lated AA. The encapsulation efficiency was determined 
as the difference between the amounts of AA added 
to the formulation (100%) and present in the filtrate 
(non-encapsulated AA). The quantification of AA was 
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performed by HPLC, with UV detection at 250 nm. The 
separation was performed using a HyperClone C18 col-
umn (250 × 4.6  mm, 5  μm), with a mobile phase con-
sisting of a 95:5 (v/v) mixture of methanol and 1% (v/v) 
acetic acid. Quantification employed an analytical curve 
(y = 1.99x – 5.83) with correlation coefficient of 0.99903, 
limit of detection (0.277  µg   mL−1) and quantification 
(0.926 μg  mL−1).
AA release kinetics and mathematical modeling
The profiles of AA release from the nanoparticles were 
evaluated using a two-compartment system composed 
of a donor compartment (2  mL) and an acceptor com-
partment (50  mL), separated by a cellulose membrane 
(1000  Da exclusion pore size) under slight stirring and 
room temperature (25 ºC). Aliquots (1 mL) were periodi-
cally collected from the acceptor compartment, with the 
volume being replaced with 1 mL of water to maintain a 
constant volume. The aliquots removed were analyzed 
by HPLC and the results were converted to percentages 
of released AA. The assays were performed in triplicate. 
Zero order, first order, Higuchi and Korsmeyer-Peppas 
mathematical models were used to elucidate the release 
mechanism of AA from all formulations [25].
AA oxidation kinetics
The oxidation profiles of AA, alone and encapsulated in 
the CS and PCL nanoparticles, were evaluated using the 
method described previously [26]. A stock solution of 
AA was prepared by dissolving 50 mg of AA in 250 mL 
of stabilizing solution (EDTA). The absorbance of this 
solution was measured at 265  nm, with the stabilizing 
solution used as the background. Separately, a solution 
of Oxone (potassium peroxymonosulfate, Sigma-Aldrich) 
was prepared in 50 mL of EDTA solution. An aliquot of 
AA solution was mixed with 3 mL of Oxone solution and 
completed to 25 mL with the stabilizing solution, result-
ing in a solution with 10 μg  mL−1 of AA. The same pro-
cedure was performed for the CS and PCL nanoparticles 
loaded with AA. The absorbance value of the solution 
containing only AA, minus the absorbance value of the 
solution containing AA and Oxone, was proportional to 
the concentration of AA present in the sample. For oxida-
tion studies under aquarium conditions, 9 aquaria were 
used (3 per treatment), each containing a final volume 
of 3 L and fitted with an aeration pump. The param-
eters set for the experiment were 28  °C, pH 7 ± 0.5, and 
25 µg  mL−1 of AA (the concentration used in the in vivo 
assays). At predetermined times, 1  mL aliquots were 
collected, and the amount of AA was determined using 
HPLC. The results were presented as % viable ascorbic 
acid. The assays were performed in triplicate (n = 3).
In vivo studies
Maintenance and reproduction of the animals
The breeding fish (Danio rerio, wild-type strain) were 
kept in a Rack Hydrus system (Model ZEB-40, Alesco), 
under controlled conditions of 28 ± 0.2 ºC, conductivity 
of 400 ± 0.2 µS, and pH 7.0 ± 0.2. The pH was controlled 
using solutions of 30  g  L−1 sodium bicarbonate (Synth) 
and 1  mL  L−1 HCl (37%, ACS, Scharlau). The conduc-
tivity was adjusted with 30  g/L saline solution (Red Sea 
salt or Instant Ocean). The embryos were kept in recon-
stituted water prepared according to the protocol of the 
USEPA (2002). The experiments carried out in this work 
were approved by the Animal Use Ethics Committee 
(CEUA) of Embrapa Environment (protocol nº 12/2018).
Toxicity evaluation using zebrafish
The embryos and larvae were divided into control groups 
(embryo medium only) and treatment groups with addi-
tion of ascorbic acid (AA), empty chitosan nanoparti-
cles (NPs_CS), chitosan nanoparticles loaded with AA 
(NPs_CS_AA), PCL nanoparticles (NPs_PCL), and PCL 
nanoparticles loaded with AA (NPs_PCL_AA). Prelimi-
nary tests were performed to determine the lethal con-
centration  (LC50, mg/L). For this experiment, 24-well 
polystyrene plates were used, with the embryos being 
individually exposed to 2 mL of the test solution (n = 24 
per group). The concentrations used for each exposure 
were 3.12, 6.25, 12.5, 25, 50, 100, 200, and 400 mg/L. The 
same dilutions were used for the control nanoparticles 
without the presence of AA. The positive control was 
4 mg  L−1 of 3,5-dichloroaniline (≥ 98%, Sigma-Aldrich). 
The plates were examined every 24  h to determine the 
mortality of the embryos and larvae, using a stereomi-
croscope (Model SMZ 2 LED, Optika) and Optika View 
v. 7.1.1.5 software. After 96 h of exposure, the  LC50 was 
determined for each group, using probit analysis per-
formed with Statgraphics Centurion XVII v. 1.17.04 
software.
Evaluation of fish embryo acute toxicity (FET)
The embryos were exposed to different concentra-
tions  (LC10,  LC20,  LC30,  LC40, and  LC50) of the treat-
ments (n = 24 per group). The exposure was carried 
out for 96  h under the test conditions described in 
OECD protocol 236 (OECD, 2013). The embryos were 
kept individually in 24-well polystyrene plates (n = 24 
organisms per group), with addition of 2  mL of test 
solution to each well. The temperature was maintained 
at 26 ± 0.2  °C and a light/dark photoperiod of 14/10 h 
was provided. Determinations were made of mortality 
and morphological abnormalities including changes 
in heartbeat, presence of coagulation, undetected tail, 
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change in head formation, disintegration of larvae, per-
icardial edema, yolk sac edema and opacity, and defec-
tive development of the somite.
The total length of the larvae (mm) was measured 
from the mouth to the terminal portion of the tail. The 
embryos and larvae were evaluated every 24  h, using 
a stereomicroscope to determine the occurrence of 
malformations and/or mortality. After exposure for 
96 h, the live larvae were photographed and their total 
lengths were measured using Optika View v. 7.1.1.5 
software previously calibrated with a millimeter scale.
Mortality was defined as the presence of coagulation, 
lack of heartbeat, failure of somite development, and 
undeveloped tail. The hatching rate was calculated con-
sidering the successful hatching of embryos in relation 
to the total number of embryos in each replicate. The 
observed malformations included pericardial edema, 
tail deformity, yolk sac edema, and spinal curvature. 
Pericardial edema was identified as swelling due to 
an increase in the volume of fluid in the pericardium, 
which is the portion of the coelomic cavity that sepa-
rates the heart from the body wall [27]. The presence 
or absence of an inflated swimming bladder was deter-
mined for the embryos 120  h post-fertilization (hpf ), 
using a microscope.
The malformation rate was determined considering the 
percentage of malformed larvae in relation to the total 
number of larvae that hatched during the test. At the 
end of the exposures (96 h), the larvae (n = 10 per group) 
were photographed and the total length was measured 
using the Optika View v. 7.1.1.5 software, at 2 × magni-
fication. The equipment was previously calibrated using a 
millimeter scale.
Evaluation of zebrafish motor activity
For evaluation of the behavioral alterations caused by the 
different treatments, the embryos were divided into the 
following groups: control (embryo medium only), ascor-
bic acid (AA), chitosan nanoparticles (NPs_CS), chi-
tosan nanoparticles loaded with AA (NPs_CS_AA), PCL 
nanoparticles (NPs_PCL), and PCL nanoparticles loaded 
with AA (NPs_PCL_AA). Zebrafish embryos (n = 36 per 
group) were exposed (96  h) under sublethal and acute 
toxicity conditions, using the different treatments at con-
centrations of  LC10,  LC20,  LC30,  LC40, and  LC50. After 
96  h, the larvae were distributed individually in 96-well 
plates, with each well containing 100 µL of embryo 
medium and 100 µL of test solution (total volume = 200 
µL). The behaviors of the larvae were recorded individu-
ally for 10 min (at 28 °C) and were analyzed using Etho-
visionXT software (Noldus). The parameters considered 
were speed (mm/s) and distance covered.
Evaluation of acetylcholinesterase (AChE) activity
AChE activity was determined according to the method 
described previously [28]. The embryos (2 hpf ) were 
exposed for 96  h to different concentrations  (LC10, 
 LC20,  LC30,  LC40, and  LC50) of the treatments: con-
trol (embryo medium only), ascorbic acid (AA), chi-
tosan nanoparticles (NPs_CS), chitosan nanoparticles 
loaded with AA (NPs_CS_AA), PCL nanoparticles 
(NPs_PCL), and PCL nanoparticles loaded with AA 
(NPs_PCL_AA). The exposures were performed in ster-
ile polystyrene Petri dishes. Live larvae were collected 
96  h after the start of exposure, for the determination 
of AChE activity. The larvae were washed (3 times) with 
cold (4 °C) phosphate buffer (0.5 mol/L) at pH 7.0, fol-
lowed by storage in Eppendorf microtubes containing 
0.5 mL of phosphate buffer (n = 5 pools of 10 larvae per 
group). The readings were performed in triplicate. The 
samples in phosphate buffer were homogenized with 
an ultraturrax, followed by centrifugation for 10  min 
at 10,000 g and 4 °C. The supernatant was used for the 
analysis of AChE. The protein concentrations in the 
samples were determined as described previously by 
Bradford [29]. Five pools of 10 larvae were analyzed 
for each group, with the readings performed in tripli-
cate. A 96-well microplate spectrophotometer (Sunrise, 
Tecan) was used for the analysis. The AChE activity was 
determined as described previously by Elman et  al., 
[28], modified for microplates [30]. For this, 15  μg of 
the homogenate was added to 15 µL of 9 mmol/L ace-
tylcholine (acetylthiocholine iodide, Sigma-Aldrich) 
and 70 µL of 0.75  mmol/L DTNB (5.5′-dithiobis 
(2-nitrobenzoic acid), Sigma-Aldrich). The absorbance 
at 412 nm was monitored for 5 min, at 30 °C (11 cycles, 
with 30 s between readings).
Evaluation of zebrafish body weight
Seventy zebrafish larvae with initial weight 1.8–1.9 mg 
and length 7.748–8.398  mm were distributed in 7 
aquaria with volumes of 3 L (n = 10 organisms per 
group) and were exposed to the different treatments for 
61 days. The control group was fed with commercial 
food (TetraMIN), while the other groups were fed with 
TetraMIN plus different concentrations (25, 50, and 
100  mg/kg) of chitosan nanoparticles loaded with AA 
(NPs_CS_AA) or PCL nanoparticles loaded with AA 
(NPs_PCL_AA). The fish were fed to satiety, three times 
a day. At the end of the experimental period, the fish 
were fasted for 24 h. After this period, individual meas-
urements were made of the weights and total lengths 
of the fish from each treatment. The results were pre-
sented as the means of the final weights and lengths of 
10 organisms.
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Results and discussion
Characterization of the polymeric nanoparticles
Chitosan nanoparticles cross-linked with sodium trip-
olyphosphate were prepared by the ionic gelation 
method, while polycaprolactone nanoparticles were syn-
thesized using the emulsification/evaporation method. 
In both cases, the synthesis was followed by spray dry-
ing. The physicochemical properties of the nanoparti-
cles were determined before and after the spray drying 
process.
For the chitosan nanoparticles (NPs_CS) and the 
chitosan nanoparticles containing AA (NPs_CS_AA) 
in aqueous suspension, the average diameters were 
316 ± 5  nm and 337 ± 3  nm, respectively. The polydis-
persity indexes for these nanoparticles ranged from 0.39 
to 0.40, while the zeta potentials were between 47 and 
76 mV (Table 1).
For the PCL nanoparticles (NPs_PCL) and the PCL 
nanoparticles containing AA (NPs_PCL_AA) in aqueous 
suspension, the average diameters were 329 ± 1 nm and 
350 ± 5 nm, respectively. The polydispersity indexes were 
between 0.23 and 0.34, while the zeta potentials for these 
nanoparticles were negative, with values of -19 ± 0.2 mV 
for NPs_PCL and   −  20 ± 0.1  mV for NPs_PCL_AA 
(Table  1). Both nanoparticulate systems showed high 
encapsulation efficiencies, with values of 98 ± 0.1% for 
NPs_CS_AA and 95 ± 0.4% for NPs_PCL_AA. However, 
there were significant decreases in the encapsulation effi-
ciency during storage (data not shown), which could be 
attributed to the high aqueous solubility of AA (330 g/L). 
Furthermore, it is known that AA presents rapid degra-
dation in aqueous solution. For these reasons, together 
with the fact that the objective of this work was to pre-
pare nanoparticles to be incorporated into fish diets, it 
was decided to submit these nanoparticles to a spray dry-
ing process, in order to extend the stability of the AA and 
improve its biological activity.
After drying the nanoparticles, they were resuspended 
in distilled water and their physicochemical character-
istics were determined, in order to evaluate the effect of 
the drying process. The average diameters of the chitosan 
nanoparticles (NPs_CS_SD) and the chitosan nanoparti-
cles containing AA (NPs_CS_AA_SD) presented reduc-
tions of 22 and 23  nm, respectively. Decreases of the 
polydispersity index were also observed for both formu-
lations, although the chitosan nanoparticles loaded with 
AA showed the same size distribution pattern before and 
after the spray drying process (Fig. 1A). Chitosan nano-
particles are electrostatically stabilized, so the strong 
cationic charge of the nanoparticles produced could be 
an indication of good stability of the nanoformulation. 
Another important parameter that did not undergo sig-
nificant alteration was the efficiency of encapsulation 
of AA in the chitosan nanoparticles, with a value of 
96 ± 0.5% obtained.
Similar to the behavior observed for the chitosan nano-
particles, the dried PCL nanoparticles showed reductions 
of 48 and 47  nm for NPs_PCL_SD and NPs_PCL_AA_
SD, respectively (Table  1). Decreases of the polydis-
persity index also occurred after the drying processes, 
but the size distribution was not modified, as shown in 
Fig. 1B. The zeta potentials showed small increases, com-
pared to the nanoparticles before the drying process, but 
remained negative, which is a characteristic of PCL. The 
zeta potential values for these nanoparticles were below 
the values recommended in the literature for a stable 
colloidal system. It is well known that the zeta potential 
is responsible for the colloidal stabilization of the nano-
particles in suspension, preventing their aggregation, 
due to the electrostatic repulsion of the particles, thus, 
the higher the value of the zeta potential (in module), 
the greater the electrostatic repulsion and the lower the 
tendency to form aggregates. However, in the case of the 
PCL formulations, PVA was used as a stabilizing agent, 
with the main stabilization mechanism of this surfactant 
involving steric hindrance, rather than electrostatic 
charge effects.
A high AA encapsulation efficiency (91 ± 0.2%) was 
observed, indicative of strong affinity of the compound 
for the nanoparticles. The physicochemical characteriza-
tion data demonstrated that the drying process did not 
cause changes capable of destabilizing the system, indi-
cating that this process could be applied to both types of 
nanoparticle, in order to improve the stability of AA. All 
the results presented below were performed using nano-
particles that were spray dried and subsequently resus-
pended before each experiment.
Table 1 Physicochemical characterization of the nanoparticles 
loaded with AA
The parameters determined were the mean particle diameter (MD) obtained by 
the dynamic light scattering method, polydispersity index (PDI), zeta potential 
(ZP), and encapsulation efficiency (EE). The values are the means of three 
determinations
Samples MD (nm) PDI ZP (mV) EE (%)
Nanoparticles before spray drying
 NPs_CS 316 ± 5 0.39 ± 0.13 47 ± 0.7 –
 NPs_CS_AA 337 ± 3 0.40 ± 0.01 76 ± 0.5 98 ± 0.1
 NPs_PCL 329 ± 1 0.23 ± 0.10 − 19 ± 0.2 –
 NPs_PCL_AA 350 ± 5 0.34 ± 0.10 − 20 ± 0.1 95 ± 0.4
Nanoparticles after spray drying
 NPs_CS_SD 294 ± 1 0.33 ± 0.02 41 ± 0.5 –
 NPs_CS_AA_SD 314 ± 3 0.36 ± 0.01 60 ± 1.7 96 ± 0.5
 NPs_PCL_SD 281 ± 1 0.21 ± 0.05 − 15 ± 0.2 –
 NPs_PCL_AA_SD 303 ± 1 0.28 ± 0.06 − 18 ± 0.4 91 ± 0.2
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Kinetics of AA release from the nanoparticles
The profiles of release of AA from the chitosan nanopar-
ticles (NPs_CS_AA) and the PCL nanoparticles (NPs_
PCL_AA) are shown in Fig.  2A. For non-encapsulated 
ascorbic acid, the concentration of this compound in the 
acceptor compartment was 39 ± 0.2% after 60 min, reach-
ing 51 ± 0.9% after 210 min, followed by a decrease of the 
concentration, due to degradation of the compound in 
Fig. 1 Size distributions obtained using the DLS technique. A Chitosan nanoparticles loaded with AA, before the spray drying process (NPS_CS_AA) 
(1) and after spray drying (NPs_CS_AA_SD) (2). B PCL nanoparticles containing AA, before spray drying (NPs_PCL_AA) (1) and after spray drying 
(NPs_PCL_AA_SD) (2)
Fig. 2 A In vitro release kinetics profiles for ascorbic acid (AA), chitosan nanoparticles containing ascorbic acid (NPs_CS_AA), and PCL nanoparticles 
containing AA (NPs_PCL_AA), for analyses performed in triplicate, with quantification by HPLC. Fitting of the Korsmeyer-Peppas mathematical 
model for the release of AA from B NPs_CS_AA and C NPs_PCL_AA
Page 8 of 22Luis et al. J Nanobiotechnol          (2021) 19:163 
the aqueous medium, which precluded further concen-
tration measurements for this system.
The release patterns observed for NPs_CS_AA and 
NPs_PCL_AA were similar, with faster release of AA 
in the first hour of the experiment, followed by a more 
constant release (Fig.  2A). After 60  min, releases of 
43 ± 0.1% and 30 ± 0.1% were observed for NPs_CS_AA 
and NPs_PCL_AA, respectively. In comparison with 
the non-encapsulated AA, the chitosan nanoparticles 
were not able to modify the AA release profile, with 
maximum release of 55.7 ± 0.03% after 480 min. In con-
trast, the association of AA with the PCL nanoparticles 
significantly delayed the release of AA, with release of 
42 ± 0.03% of the encapsulated AA after 480 min. A pre-
vious study evaluated the release of AA from chitosan 
nanoparticles in seawater (pH 8), with only 6.57 ± 0.52% 
of the AA released after 120  min, which was 7.6 and 5 
times less than observed here for the chitosan and PCL 
nanoparticles, during the same period of time [31]. The 
lower release of AA observed by these authors can be 
explained by the difference of the nanoparticulate sys-
tem. In this system, there is the presence of cyclodextrin, 
thus, AA is complexed with cyclodextrin, which was fur-
ther involved by CS. In this way, the AA needs to diffuse 
from the CD and later, from the CS to be released to the 
medium,thus, the 6.57 ± 0.52% release refers to the AA 
that is mainly dispersed close to nanoparticles surface.
The mechanisms of release of AA from the chitosan 
and PCL nanoparticles were investigated by application 
of the zero order, Higuchi, and Korsmeyer-Peppas math-
ematical models. The Korsmeyer-Peppas model provided 
the best fit to the release data for both the CS and PCL 
nanoparticles, with  r2 values of 0.9189 and 0.9433 for 
NPs_CS_AA and NPs_PCL_AA, respectively (Fig.  2B, 
C). For both systems, the release exponent (n) value was 
less than 0.5 (n = 0.28 for the chitosan nanoparticles and 
n = 0.38 for the PCL nanoparticles), indicating that the 
release mainly occurred by diffusion of AA through the 
swollen polymeric matrix and through the hydrophilic 
pores (Fickian diffusion). The release constants (k) for 
the chitosan and PCL nanoparticles were 0.1899 and 
0.07912  min−1, respectively, indicating that faster release 
of AA occurred from the CS nanoparticles, compared to 
release from the PCL nanoparticles. Brito & colleagues 
evaluated the release of hydro soluble vitamins from chi-
tosan nanoparticles. The release constant (k) for vitamin 
C released from chitosan nanoparticles at pH 7.4 and 
pH 3 were 1.0 and 1.4   min−1 respectively [32]. In other 
hand, when the release rate of vitamin C was evaluated 
from polycaprolactone-polyethylene glycol microparti-
cles in three different pH (2.8, 7.4 and 9.6), the obtained 
values were between 0.0127 to 0.0493  min−1 [33]. In this 
way, the results found here corroborate with previous 
published results in the literature, where the release rate 
of AA is faster when encapsulated into chitosan nanopar-
ticles in comparison to PCL nanoparticles.
AA oxidation kinetics
The oxidation of AA can occur according to both anaero-
bic and aerobic mechanisms, depending on the avail-
ability of oxygen. In the non-oxidative pathway, AA is 
hydrolyzed to produce an acyclic structure. In the oxi-
dative pathway, oxidation occurs due to the presence of 
oxygen, producing dehydroascorbic acid [34]. The oxi-
dation of ascorbic acid was induced by the presence of 
peroxymonosulfate, resulting in a two-stage reaction in 
which an ascorbate free radical is firstly produced, fol-
lowed by the donation of a second electron to produce 
dehydroascorbic acid, in a reversible process. Dehy-
droascorbic acid undergoes a ring opening reaction, 
resulting in 2,3-diketogulonic acid and causing loss of 
vitamin activity [26]. Figure  3 shows the oxidation pro-
files of non-encapsulated AA and AA encapsulated in the 
chitosan or PCL nanoparticles.
For the non-encapsulated AA, addition of the oxidiz-
ing agent to the solution resulted in a fourfold decrease 
(2.5 ± 0.01  µg/mL) of the AA concentration, relative to 
the initial value, in the first minute of the experiment 
(Fig.  3A). Total degradation of the AA present in the 
solution was observed after 7 min. The AA present in the 
chitosan NPs also showed rapid (2.6-fold) degradation 
during the first minute of the experiment, in the presence 
of the oxidizing agent. Nonetheless, the encapsulation of 
AA in the chitosan NPs was able to decrease the degrada-
tion rate, which stabilized between 2 and 8 min, followed 
by progressive degradation until complete removal of the 
AA after 20  min. Encapsulation of AA in the PCL NPs 
resulted in much slower degradation of the compound, 
with total degradation only reached after 8 h.
In addition, the degradation of AA, free or encapsu-
lated in the CS and PCL nanoparticles, was evaluated in 
aquarium simulations representing the normal condi-
tions of the fish environment (Fig. 3B). This experiment 
with a constant aeration system simulated the natural 
degradation of AA in aquaculture systems, where there is 
continuous movement of the water. It has been reported 
that greater movement of water (solvent) accelerates the 
degradation of AA [35].
As shown in Fig.  3B, faster degradation was observed 
for the non-encapsulated AA. In the first 60 min of the 
experiment, almost half of the AA present in solution 
had already been degraded, while no AA remained in the 
solution after 120 min, showing that the AA was totally 
degraded. For the NPs_CS_AA and NPs_PCL_AA, the 
AA degradation rates were slower, with 60.88 ± 0.05% 
and 67.15 ± 0.52% of the AA remaining after 60 min, and 
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total degradation of AA after 360 and 480  min, respec-
tively. These results demonstrated the effectiveness of the 
nanosystems in protecting AA against degradation and 
corroborated the data obtained using the peroxymono-
sulfate oxidizing agent. In addition, these results showed 
that under aquarium conditions, the use of the nanopar-
ticles could promote an increase in the amount of AA in 
solution, compared to non-encapsulated AA. The results 
obtained in these tests corroborated the release data, 
with the greater degradation observed for NPs_CS_AA 
being due to the faster release of the compound, com-
pared to the release from NPs_PCL_AA, with the latter 
promoting a more sustained release of the AA protected 
within the nanoparticles.
AA solutions are highly susceptible to rapid degra-
dation and oxidation by oxygen dissolved in alkaline 
solutions [36]. Stevanovic et  al. [37] prepared poly(D,L-
lactide-co-glycolide) nanospheres for the encapsulation 
of ascorbic acid and evaluated the in  vitro degradation 
of the particles in the presence and absence of ascorbic 
acid. In both cases, degradation and complete release of 
the ascorbic acid occurred after 8 weeks. Only 10% of the 
ascorbic acid was released in the first 24 days, after which 
agglomeration of the particles resulted in the formation 
of a porous film. The encapsulation of AA in the nano-
particles provided protection against reactions, tempera-
ture, humidity, and oxygen, consequently improving both 
stability and bioavailability.
The degradation of AA is influenced by factors includ-
ing oxygen, pH, temperature, metal ions, enzymes, light, 
water activity, and oxidizing agents (nitrite), among oth-
ers [38]. Studies have mainly focused on the degradation 
of ascorbic acid in fruits and other foods, which generally 
follows first order kinetics [39]. When oxygen is present, 
the rate of degradation of AA is faster [40]. This work is 
the first study of the oxidation of AA (99% purity) encap-
sulated in polymeric nanoparticles, comparing the results 
obtained with induction using peroxymonosulfate and 
under aquarium conditions, which opens up new oppor-
tunities for future research.
Toxicity evaluation using zebrafish
The use of nanomaterials has grown exponentially, 
accompanied by increasing concerns about their toxici-
ties due to occasional or occupational exposures. Several 
factors can influence the toxicity of the materials, both 
intrinsic to them (size and shape, surface charge, com-
position, and state of agglomeration, among others) 
and extrinsic (such as pH, ionic strength, and medium 
composition). In this work, the  LC50 values were deter-
mined for non-encapsulated AA, chitosan nanoparticles, 
chitosan nanoparticles containing AA, PCL nanoparti-
cles, and PLC nanoparticles containing AA. Zebrafish 
embryos were used as a model organism, following the 
OECD 236 protocol (OECD, 2013). The concentrations 
used were 3.12, 6.25, 12.5, 25, 50, 100, 200, and 400 mg 
 L−1. The accumulated mortality percentage was meas-
ured after 96 h (Fig. 4A).
The groups treated with non-encapsulated AA showed 
mortality rates below 30% for all the concentrations 
tested, with the exception of the highest concentration 
(400 mg  L−1), where mortality was 75% (Fig. 4A), which 
could have been due to the pro-oxidant effect of AA at 
high concentrations, causing oxidative damage to DNA 
[41].
When AA was encapsulated in the chitosan NPs (NPs_
CS_AA), mortality of less than 20% was observed up to 
a concentration of 50  mg  L−1, while higher concentra-
tions caused 100% mortality of the organisms. Chitosan 
nanoparticles without encapsulated AA (NPs_CS) were 
Fig. 3 Oxidation of non-encapsulated ascorbic acid (AA) and ascorbic acid encapsulated in chitosan nanoparticles (NPs_CS_AA) and PCL 
nanoparticles (NPs_PCL_AA). The oxidation of ascorbic acid was A induced using peroxymonosulfate and B occurred under aquarium conditions 
simulating the natural environment of fish
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Fig. 4 A Mortality rates of embryos and larvae exposed to the different treatments (control, AA, NPs_CS, NPs_CS_AA, NPs_PCL, and NPs_PCL_AA) 
at different concentrations (3.12, 6.25, 12.25, 25, 50, 100, 200, and 400 mg/L). B–F Hatching rates of embryos exposed to ascorbic acid (AA), chitosan 
nanoparticles (NPs_CS), chitosan nanoparticles containing AA (NPs_CS_AA), PCL nanoparticles (NPs_PCL), and PCL nanoparticles containing AA 
(NPs_PCL_AA). For the statistical tests, ANOVA (two-way, significance of p < 0.05) was used to observe the statistical differences between groups 
with the same concentration, where a indicates a statistically significant difference, compared to the control group
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also tested at the same dilutions as the NPs containing 
AA (Fig.  4A). These formulations were more toxic to 
the zebrafish, with a concentration of 50 mg  L−1 causing 
100% mortality of the organisms. The zebrafish treated 
with PCL nanoparticles (NPs_PCL) and PCL nanoparti-
cles containing AA (NPs_PCL_AA) showed concentra-
tion-dependent mortality. In both cases, mortality of less 
than 50% was observed up to a concentration of 100 mg 
 L−1. However, the highest concentration (400  mg/L) 
caused 100% mortality.
The mortality data indicated that the chitosan nano-
particles were more toxic to the zebrafish embryos and 
larvae, compared to the PCL nanoparticles. Probit anal-
ysis, performed with Statgraphics Centurion XVII v. 
1.17.04 software, enabled calculation of the  LC50,  LC40, 
 LC30,  LC20, and  LC10 values for the different formulations 
tested (Table 2).
The  LC50 for non-encapsulated AA was 330.7  mg 
 L−1, while reductions of 11.4-fold and 5.7-fold, respec-
tively, were observed for the  LC50 values of the chitosan 
nanoparticles (28.9  mg  L−1) and chitosan nanoparticles 
containing AA (57.4 mg/L), compared to the non-encap-
sulated AA. The  LC50 values for the NPs_PCL and NPs_
PCL_AA formulations were 168.9 and 179.6  mg  L−1, 
respectively, around twofold lower than the  LC50 for the 
non-encapsulated AA.
The  LC50 was significantly higher after the encapsula-
tion of AA in the chitosan nanoparticles (NPs_CS_AA), 
compared to the nanoparticles alone (NPs_CS). This 
increase could have been related to the ability of ascorbic 
acid to modulate or decrease genotoxicity, regenerating 
other oxidants and removing free radicals.
Similar results were obtained elsewhere for the 
 LC50 of chitosan nanoparticles for zebrafish embryos 
 (LCß = 23.26 mg  L−1) [42]. In this case, the encapsulated 
ascorbic acid acted to reduce the toxic effects of the chi-
tosan particles [41].
The incorporation of AA into the NPs_PCL system also 
decreased the mortality rate, which could be attributed 
to the effect of AA in reducing toxicity. This effect was 
reported by Stevanović et  al. [43], who found that the 
incorporation of ascorbic acid significantly reduced gen-
otoxicity in Oreochromis mossambicus exposed to ethyl 
methanesulfonate. Sarma et al. [44] found that the incor-
poration of ascorbic acid in the diet reduced the toxicity 
of the acaricide endosulfan, tested using Channa puncta-
tus. The antioxidant activity of AA can act to decrease the 
toxicity of certain compounds. However, the observed 
behavior may have been more related to the release of 
AA from the NPs.
The toxicity of PCL nanoparticles has been evaluated 
in other in  vitro and in  vivo studies. Quercetin-loaded 
polycaprolactone microspheres were evaluated for their 
in vitro cytotoxicity in synovial cells [45]. The treatments 
were carried out for 48 h, in the presence and absence of 
the active substance (quercetin). The results showed that 
the PCL microspheres caused cytotoxicity in the cells, 
suggesting that the system could be used in future treat-
ment methodologies. In other work, Youssouf et al. [46] 
tested the effects of oligo-carrageenan micelles grafted 
with polycaprolactone, containing curcumin. It was 
found that the micelles were not cytotoxic in zebrafish 
and that they also decreased the anti-inflammatory 
effects of curcumin and improved cell absorption. It was 
concluded that the micelles were safe nanocarriers.
In addition to mortality, evaluation was made of the 
influence of the formulations on the hatching of zebrafish. 
The embryos were exposed to non-encapsulated AA, chi-
tosan NPs (NPs_CS), chitosan NPs containing AA (NPs_
CS_AA), PCL NPs (NPs_PCL), and PCL nanoparticles 
containing AA (NPs_PCL_AA), at concentrations of up 
to 200, 25, 50, and 100 mg  L−1, respectively. The concen-
trations were defined according to the mortality tests and 
concentrations higher than the  LC50 of each formulation 
were not used.
The hatching rates of the embryos were lower after 
48 h of exposure to AA, compared to the control group 
(Fig.  4B). However, after 96  h, the hatching rate of the 
embryos exposed to a concentration of 50  mg/L was 
similar to that of the control group. For concentrations 
of 100 and 200  mg  L−1, more pronounced decreases in 
hatching were observed after 96  h of treatment. Lower 
hatching rates were also observed for the embryos 
exposed to the chitosan NPs (Fig. 4C). However, for these 
groups, the hatching decreased in a dose-dependent 
manner, according to the increase in the concentration 
of nanoparticles. Interestingly, when the embryos were 
Table 2 Average lethal concentrations (mg/L) for zebrafish 
embryos and larvae exposed to different treatments: 
ascorbic acid (AA), chitosan nanoparticles (NPs_CS), chitosan 
nanoparticles containing ascorbic acid (NPs_CS_AA), PCL 
nanoparticles (NPs_PCL), and PCL nanoparticles containing AA 
(NPs_PCL_AA)
The concentrations tested for each exposure were  LC10,  LC20,  LC30,  LC40, 
and  LC50. The LC values after 96 h of exposure were determined by probit 
analysis, employing Statgraphics Centurion XVII v. 1.17.04 software (Stat Point 
Technologies, 2014). The plates were analyzed using a stereomicroscope (Model 
SMZ 2 LED, Optika), at 2 × magnification
LC – 96 h 
(mg/L)
AA NPs_CS NPs_CS_AA NPs_PCL NPs_PCL_AA
LC50 330.7 28.9 57.4 168.9 179.6
LC40 275.8 24.8 48.1 137.5 146.1
LC30 217.1 20.3 38.1 103.8 110.2
LC20 148.3 15.2 26.4 64.5 68.2
LC10 53.0 8.0 10.2 9.9 10.0
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exposed to nanoparticles loaded with AA, the hatching 
rate was also lower, compared to the control group, but 
hatching increased with increase of the concentration of 
nanoparticles, after 96  h of exposure (Fig.  4D). For the 
embryos treated with the PCL NPs, the hatching rate was 
inversely proportional to the concentration of nanoparti-
cles present in the medium, with a higher concentration 
of NPs resulting in a lower hatching rate (Fig. 4E). All the 
concentrations tested caused a significant reduction in 
the hatching rate after 96 h of exposure, with the excep-
tion of the lowest concentration tested (3.12 mg  L−1). For 
the embryos exposed to the PCL NPs containing AA, as 
well as those exposed to the chitosan nanoparticles, the 
hatching rate increased with increase of the concentra-
tion of NPs in the medium (Fig. 4F).
Similar results were reported by Hu et  al. [47], who 
evaluated the toxicity of chitosan nanoparticles and chi-
tosan nanoparticles containing Tween 80, with average 
sizes of 247 ± 20 and 251 ± 15  nm, respectively, using 
zebrafish as a model organism. Dose-dependent decrease 
of the hatching rate and increase of mortality were 
observed for both formulations, with an embryo mortal-
ity rate of around 100% at a concentration of 50  mg/L. 
The  LC50 values for the chitosan nanoparticles and the 
chitosan nanoparticles containing Tween were 23.26 and 
25.06  mg  L−1, respectively, which were very similar to 
those found in this study (Table 2).
Hu et  al. [47] found that chitosan nanoparticles with 
sizes of 200 and 340  nm caused significant mortality of 
zebrafish embryos, compared to the positive control 
(ZnO nanoparticles), at concentrations of 40 and 30 mg 
 L−1, respectively. For both types of nanoparticle, the tox-
icity to the embryos was dose- and time-dependent, with 
the smaller nanoparticles having greater toxic effects.
In contrast, Wang et  al. [48] tested the toxicity of 
chitosan nanoparticles (84.86  nm) towards zebrafish 
embryos, using different concentrations (150 to 400  mg 
 L−1), obtaining an  LC50 approximately tenfold higher 
(280 mg  L−1) than found in the present study. In another 
zebrafish toxicity study, Abou-Saleh et al. [49] found that 
chitosan nanoparticles in the size range 100–150 nm pre-
sented no toxic effects until the highest concentration 
tested (200 mg  L−1). These differences between the stud-
ies suggest the need for further research investigating the 
effects of different preparation methods, since it is pos-
sible that specific components of the nanoparticles could 
have induced toxic effects in the zebrafish embryos.
Evaluation was also made of morphological changes in 
the zebrafish embryos and larvae (Additional file 1: Fig-
ure S1). For all groups exposed to low concentrations, no 
abnormalities were observed in the embryos and larvae. 
However, high concentrations caused toxic effects includ-
ing edema and opacity of the yolk sac, tail malformation, 
clotted egg, change in head formation, and disintegra-
tion of larvae. The non-encapsulated AA caused effects at 
concentrations of 25 and 50 mg  L−1, with the organisms 
showing higher numbers of malformations, compared 
to the organisms exposed to AA encapsulated in the 
NPs_CS_AA, at the same concentrations. After exposure 
to 100 mg  L−1 of NPs_ CS_ AA, the larvae disintegrated 
after hatching. The embryos showed changes in the for-
mation of the head and were coagulated when exposed 
to NPs_CS concentrations of 50 mg  L−1 or higher (Addi-
tional file 1: Figure S1).
Malformations were also observed in the animals 
treated with PCL nanoparticles and PCL nanoparti-
cles containing AA. However, at the same concentra-
tion (100  mg  L−1), fewer types of malformations were 
observed in the animals exposed to NP_PCL_AA, com-
pared to non-encapsulated AA (Additional file 1: Figure 
S1). It should be noted that ascorbic acid (AA) is a vita-
min and has limited toxicity, although high concentra-
tions (above 200  mg  L−1) can cause some toxic effects. 
The results showed that the chitosan nanoparticles had 
toxic effects in the embryos, but were less toxic when 
combined with ascorbic acid, which led to fewer mor-
phological abnormalities and a higher hatching rate, due 
to the controlled release of AA from the NPs.
The results indicated that concentrations of up to 50 
and 100 mg  L−1 of AA encapsulated in NPs_CS_AA and 
NPs_PCL_AA, respectively, would be promising for the 
incorporation of these systems as a vehicle for this vita-
min in fish feed. These doses are higher than those neces-
sary for the satisfactory development of fish [50, 51]. For 
the incorporation of AA in the feed, advantages of the 
systems proposed here are that they can reduce oxida-
tion of the compound and prolong its shelf life, due to the 
high encapsulation efficiency (above 90%, for both nano-
particulate systems), providing stability during 90 days of 
storage (data not shown).
Evaluation of fish embryo acute toxicity (FET)
The morphological changes (Additional file 1: Figure S2) 
of the embryos and larvae were evaluated for 96 h expo-
sure to different concentrations  (LC10,  LC20,  LC30,  LC40, 
and  LC50) of all the formulations. After fertilization, the 
embryos were individually exposed in 24-well polysty-
rene plates kept in an incubator at 26 ± 1  °C. The lethal 
effect on the embryos was indicated by the absence of 
somites, egg coagulation, and loss of independent move-
ment. Hatching was used to assess toxicity, since it is 
influenced by several environmental and endogenous fac-
tors. Figure  5 shows the daily rate of embryo hatching. 
For all treatments, at the lowest concentrations tested 
 (LC10 and  LC20), hatching started after 48 h of exposure, 
while at higher concentrations, hatching started after 
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72 h of exposure. For embryos treated with non-encapsu-
lated AA, hatching decreased in a dose-dependent man-
ner, with only 16.6% of the embryos hatching after 96 h 
of exposure at the highest concentration tested  (LC50) 
(Fig.  5A). Although ascorbic acid has an antioxidant 
effect, at high concentrations it can act as a pro-oxidant, 
causing oxidative damage to DNA [41].
The embryos treated with PCL nanoparticles at the 
 LC50 concentration showed a hatching rate of 66.7% 
after exposure for 96  h, which was 1.4-fold lower than 
observed for the control group after the same exposure 
time. In contrast, the hatching rate values for the ani-
mals treated with NPs_PCL_AA were higher than 79% 
for all the concentrations tested. In the case of NPs_
CS_AA, the hatching rate increased with increase of the 
concentration of AA present in the medium. For the ani-
mals exposed to the  LC50 concentration, the hatching rate 
after 96  h was 95.8%, which was the same as the value 
observed for the control after 96  h. These results indi-
cated that the sustained release of AA acted to reduce the 
effects of the nanoparticles on the hatching of embryos, 
since in the presence of AA there was no significant dif-
ference for this parameter, when compared to the control 
group.
Embryo malformation was assessed using images 
obtained with a stereomicroscope (Model SMZ 2 LED, 
Optika), at 2 × magnification. Additional file 1: Figure S2 
shows the malformations of embryos and larvae observed 
for each treatment at the  LC50 dose, after 96 h of expo-
sure. Regardless of the treatment, the embryos presented 
Fig. 5 Hatching rates of embryos and larvae exposed to the treatments at different concentrations  (LC10,  LC20,  LC30,  LC40, and  LC50): A ascorbic 
acid (AA), B chitosan nanoparticles (NPs_CS), C chitosan nanoparticles containing AA (NPs_CS_AA), D PCL nanoparticles (NPs_PCL), and E PCL 
nanoparticles containing AA (NPs_PCL_AA). For the statistical tests, ANOVA (two-way, significance of p < 0.05) was used to identify differences 
between the groups, where a indicates a statistically significant difference, compared to the control group
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malformation of the yolk sac. However, the embryos 
exposed to non-encapsulated AA showed greater severity 
and number of abnormalities such as edema and opacity 
of the yolk sac, edema of the pericardium, malformation 
of the tail, and bent spine.
All these teratogenic alterations, with the exception of 
tail malformation, were also observed for the embryos 
treated with chitosan nanoparticles. Embryos exposed 
to the PCL nanoparticles showed malformation, edema, 
and opacity of the yolk sac, as well as pericardial edema. 
These same malformations, except pericardial edema, 
were observed for the embryos treated with PCL nano-
particles containing AA.
Hu et  al. [47] also observed dose-dependent malfor-
mations including bent spine and opaque yolk, follow-
ing exposure of the organisms to chitosan nanoparticles 
(mean diameter of 200 nm). However, no significant mal-
formations were observed in embryos exposed to chi-
tosan nanoparticles with mean diameter of 340 nm. Yuan 
et al. [42] observed non-inflated swim bladder and bent 
spine in embryos exposed to both chitosan and chitosan/
Tween 80 nanoparticles.
The embryos treated with nanoparticles containing AA 
showed only edema and opacity of the yolk sac. Encapsu-
lation of the AA led to decreased toxicity, evidenced by 
fewer malformations, compared to the non-encapsulated 
compound and the control nanoparticles. These results 
suggested that the interaction between ascorbic acid and 
nanoparticles could decrease the toxic effect of the car-
rier system, while providing efficient release of the active 
compound.
Evaluation of zebrafish motor activity
The use of zebrafish as a model for behavioral studies 
opens up new possibilities for assessing the toxicity of 
nanoparticles. In order to identify the effects of the treat-
ments on motor development, evaluation was made of 
the speed of the zebrafish larvae and the distance trave-
led. Prolonged exposure to stressors can generate an 
adaptation response, consequently affecting the health 
of the body. When exposed to harmful compounds, fish 
may show stress responses such as slowing down, in 
order to save energy, or adoption of avoidance behavior, 
in order to increase the chance of survival [52].
Analysis was made of the behavioral biomarkers (speed 
and distance covered) for larvae exposed to different con-
centrations  (LC10,  LC20,  LC30,  LC40, and  LC50) of the for-
mulations (non-encapsulated AA, chitosan nanoparticles 
(NPs_CS), chitosan nanoparticles containing AA (NPs_
CS_AA), PCL nanoparticles (NPs_PCL), and PCL nano-
particles containing AA (NPs_PCL_AA). The embryos 
were exposed for 96 h, with subsequent evaluation of dis-
tance and speed using EthovisionXT software (Fig. 6).
Both the larvae exposed to non-encapsulated AA and 
the larvae exposed to chitosan nanoparticles contain-
ing AA showed a dose-dependent increase in the dis-
tance traveled, with higher concentrations resulting in 
greater distances traveled (Fig.  6A). Compared to the 
control group, the distance traveled was shorter, up to 
the  LC30 concentration, for the animals exposed to AA 
and those exposed to NPs_CS_AA. However, for non-
encapsulated AA at the  LC50, there was a significant 
(p < 0.05) increase in the distance traveled, compared 
to the control group, whereas use of the encapsulated 
ascorbic acid (in both types of nanoparticle) at the  LC50 
did not result in a significant difference in the distance 
traveled, compared to the control. The larvae exposed 
to the chitosan and PCL nanoparticles (without ascor-
bic acid) presented dose-dependent reductions in the 
distance traveled, compared to the control group.
The swimming speed behavior was similar to that for 
the distance covered. Larvae treated with non-encap-
sulated AA and AA encapsulated in chitosan and PCL 
nanoparticles showed dose-dependent increases in 
speed, while larvae treated with chitosan and PCL nan-
oparticles (without ascorbic acid) presented decreased 
swimming speed with increased concentration of nan-
oparticles in the medium (Fig.  6B). There is a known 
relationship between speed and distance traveled, 
where the increased swimming activity may be driven 
by the escape instinct or the response to stress [53].
The external integument or skin is a form of protec-
tion for fish, with the mucosa and scales playing impor-
tant roles in protecting against pathogens, in addition 
to providing osmoregulatory and respiratory func-
tions [54, 55]. The motor behavior inhibition caused 
by the chitosan and PCL NPs could have been due to 
the mucoadhesiveness of the nanoformulations, since 
fish epithelial cells are coated with a mucus layer rich 
in mucopolysaccharides and mucoproteins, enabling 
nanoparticles to adhere to the gills and skin [16]. The 
absence of the antioxidant effect of AA may have influ-
enced the results, since for both types of nanoparti-
cle containing AA, the locomotion activity gradually 
increased with increase of the AA concentration. Lar-
vae exposed to the  LC40 and  LC50 concentrations of 
both systems (NPs_CS_AA and NPs_PCL_AA) were 
more active, compared to the control group.
However, different to the present findings, previous 
studies found that the treatment of embryos with chi-
tosan nanoparticles caused an abnormal increase in loco-
motion activity (hyperactivity), compared to the control 
group [42, 49]. It was suggested that the chitosan nano-
particles were able to negatively affect the embryo nerv-
ous system, but did not affect muscular development. 
As noted by Wong et  al. [56], anomalies observed in 
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locomotion can be caused by changes in neuromuscular 
function and problems with neuronal innervations or 
muscles.
The increases in activity of the AA, NPs_CS_AA, and 
NPs_PCL_AA groups could be related to the electrical 
signals of primary motor neurons, on which tail move-
ment and increased swimming depend [57]. Primary 
motor neurons can periodically or spontaneously depo-
larize [58], with the frequency of this depolarization 
being related to the behavior of the fish, whereby 
increases in the electrical signals and muscle contrac-
tion lead to increases of speed and the distance traveled. 
For the organisms exposed to NPs_CS and NPs_PCL, 
the locomotion activity was lower in comparison with all 
the other groups tested, with no significant differences 
between the treatments. It is likely that the larvae were 
in a process of habituation, defined as a decrease in the 
conduct response, due to sensory or motor fatigue [59].
Fig. 6 Evaluation of the motor development biomarkers A distance traveled and B speed for zebrafish (Danio rerio) larvae exposed to the different 
treatments: control, ascorbic acid (AA), CS nanoparticles (NPs_CS), CS nanoparticles containing ascorbic acid (NPs_CS_AA), PCL nanoparticles (NPs_
PCL), and PCL nanoparticles containing ascorbic acid (NPs_PCL_AA). The exposures were performed for 96 h at different concentrations  (LC10,  LC20, 
 LC30,  LC40, and  LC50). For the statistical tests, ANOVA (two-way, significance of p < 0.05) was used to evaluate differences among the groups, with α, β, 
δ, σ, and λ indicating statistically significant differences from the control,  LC10,  LC20,  LC30, and  LC40 groups, respectively (n = 9)
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For both types of nanoparticle containing AA, the loco-
motion activity gradually increased with increase of the 
AA concentration, with the  LC50 concentration causing 
the larvae to become more active than the organisms in 
the control group. In addition to these factors, the dis-
tance traveled by the zebrafish larvae was also related 
to the energy reserve provided by the yolk sac or yolk 
vesicle, which stores a nutrient substance (calf ) respon-
sible for providing the embryo with nutrients from the 
beginning of development until the start of exogenous 
feeding by the larva [60]. The loss of nutrients or fail-
ures in the absorption of nutrients from the yolk sac can 
result in decreased embryonic growth, due to decreased 
blood flow and cardiac changes [61–63]. Other changes 
observed include pericardial edema, yolk sac edema, 
opaque yolk, tail malformation, and bent spine.
Evaluation of acetylcholinesterase (AChE) activity
In the areas of neuropharmacology and neurotoxicol-
ogy, zebrafish provides a very useful model for study of 
the effects of different compounds, enabling investiga-
tion of mechanisms of action as well as functional effects, 
such as behavioral changes. Swimming behavior can be 
used as a sensitive endpoint for detection of the sublethal 
effects of pollutants in fish [64].
The specific AChE activity was determined for the 
larvae exposed to the different treatments (non-encap-
sulated AA, chitosan nanoparticles (NPs_CS), chi-
tosan nanoparticles containing AA (NPs_CS_AA), PCL 
nanoparticles (NPs_PCL), and PCL nanoparticles con-
taining AA (NPs_PCL_AA)) at different concentrations 
 (LC10,  LC20,  LC30,  LC40, and  LC50). Statistical analysis 
employed the Kruskal–Wallis test (p = 0.05) followed by 
the Dunn test (Fig. 7).
Most of the treatments caused a significant dose-
dependent decrease in AChE activity, compared to the 
negative control. An exception was the chitosan nanopar-
ticles containing encapsulated AA, at the lowest concen-
tration tested  (LC10), where the activity of this enzyme 
was significantly higher, compared to the control group. 
Wong et al. [65] showed that the inhibition of the AChE 
enzyme by nanoparticles can be caused by its adsorption 
or interaction with the particles. It was observed that fol-
lowing adsorption, the nanoparticles inhibited AChE dif-
ferently, depending on their chemical composition.
ACh plays a crucial role in the central and neuromus-
cular synapses of the cholinergic system. When ACh 
is released into the synaptic cleft, it is rapidly degraded 
by AchE [66]. Since AChE is the enzyme responsible for 
ending cholinergic activity in the synaptic cleft, AChE 
inhibition leads to accumulation of the neurotransmit-
ter acetylcholine (ACh), resulting in increased stimula-
tion of cholinergic neurons. Consequently, inhibition of 
the AChE enzyme can affect the balance and locomotion 
of the exposed animals. Excessive hydrolysis of ACh by 
AChE may lead to muscle hypoactivity and decreased 
behavioral responses [67]. In severe cases, it can also 
cause collapse of the central nervous system, resulting 
Fig. 7 Acetylcholinesterase (AChE) activities of zebrafish larvae after exposure for 96 h to different concentrations  (LC10,  LC20,  LC30,  LC40, and  LC50) of 
ascorbic acid (AA), CS nanoparticles (NPs_CS), CS nanoparticles containing AA (NPs_CS_AA), PCL nanoparticles (NPs_PCL), and PCL nanoparticles 
containing AA (NPs_PCL_AA), compared to the control. For the statistical tests, Kruskal-Wallis test (p < 0.05) followed by Dun test was used to 
evaluate differences among the groups, with α, β, δ, σ, and λ indicating statistically significant differences from the control,  LC10,  LC20,  LC30, and  LC40 
groups, respectively (n = 9)
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in loss of muscle control or even death [68, 69]. Also, 
the cholinergic system may be involved in morphomet-
ric alterations such as curvature of the fish tail, due to 
abnormal muscle development caused by inhibition of 
acetylcholinesterase activity and the lack of hydrolysis 
of AChE [70, 71]. Hence, it is important to establish the 
relationship between locomotion behavior and biochemi-
cal responses such as AChE activity [21].
Alteration of this enzyme activity can lead to motor 
function impairment in zebrafish, due to the change 
in ACh levels at the neuromuscular junction [21, 72]. 
Behavioral impairment of silver catfish has been attrib-
uted to inhibition of cerebral AChE activity and oxidative 
damage [73]. Similarly, Baldissera et  al. [74] suggested 
that exposure to aquaculture-relevant concentrations 
(11  mg  L−1) of trichlorfon, an organophosphate pesti-
cide, could elicit behavioral abnormalities associated with 
impairment of locomotion activity, a condition that can 
be caused by cerebral oxidative damage, depression of 
the antioxidant defense system, and inhibition of AChE 
activity [75]. Studies have suggested the existence of a 
threshold relationship between AChE inhibition and 
swimming performance. Sandahl et al. [76] observed sig-
nificant decreases in swimming activity at an exposure 
concentration of chlorpyrifos as low as 0.6 µg  L−1, corre-
sponding to a relative AChE activity of 77.2%, compared 
to the control.
Tierney et al. [77] suggested that the AChE inhibition 
threshold was determined by the type of muscle used 
for any given swimming modality (swimming powered 
by aerobic muscle, or swimming powered anaerobically, 
depending on the difference in the amounts of red and 
white tissues). Critical swimming capacity may remain 
available, even when AChE inhibition reduces spontane-
ous swimming activity. This suggests that any anticho-
linesterase exposure impairing spontaneous swimming, a 
swimming mode that enables foraging, may still leave fish 
with maximum swimming performance, leading to a pro-
portional increase in the use of white muscle, which may 
differentially impair swimming behaviors such as preda-
tor avoidance.
However, for these observed effects, it can be difficult 
to distinguish between cholinergic (central and periph-
eral) mechanisms and other systems that participate in 
the processes of locomotion and swimming. It is inter-
esting that two organophosphate pesticides (chlorpyrifos 
and malathion) were found to cause opposing behaviors 
in zebrafish larvae, related to swim speed (hyperactiv-
ity vs. hypoactivity) and rest. The swim speed and rest 
behaviors appeared to be correlated to AChE activity in 
larvae treated with chlorpyrifos, but not in larvae treated 
with malathion [78]. The findings suggest that there may 
be other neural parameters that are affected and that 
influence larval behavioral changes. Gene modulation 
may be involved in cholinergic neurotransmission [79], 
while pharmacological and optogenetic manipulations of 
cholinergic neurotransmission in the hippocampal and 
amygdala regions suggest a specific role of cholinergic 
receptors in modulating the conditioned fear and extinc-
tion responses [75]. Furthermore, in rapid acceleration 
movements, red muscle not only produces power, but 
also has an important role in tuning the effective body 
stiffness. The ongoing activity of red muscle may be a 
consequence of the motor neuron recruitment pattern 
for red and white muscle, with motor neurons for red 
muscle being recruited earlier, due to their low resist-
ance, and remaining activated even when motor neurons 
for white muscle are recruited [80].
It is also interesting to note that ascorbic acid plays a 
role in neuronal differentiation, maturation, myelin for-
mation, and modulation of neurotransmission, as in 
cholinergic systems [81]. Based on these results, it is 
plausible that AA interferes with the cholinergic sys-
tem, depending on the dose and possibly the fish stage of 
development. Although, in the present study, a decrease 
in AchE levels was observed, Narra et  al. [82] showed 
that the acetylcholinesterase activity of rockfish was sig-
nificantly increased by dietary AA supplementation, 
mitigating chlorpyrifos toxicity. In addition, dietary AA 
supplementation in the rockfish induced an increase 
in AChE activity [83]. Hence, it is not yet clear whether 
chitosan can affect the role of AA in development of 
the cholinergic neurotransmitter system, since chitosan 
nanoparticles can remain adhered to the mucosal sur-
faces of fish [16]. Another possibility is that the AA kinet-
ics induced by nanoparticles, at the larval development 
stage selected here, might influence the enzyme activity 
at maturity, resulting in a non-synergistic effect.
Since locomotion behavior in organisms is important 
for avoiding predators, seeking food, and reproduction, 
it is a parameter of considerable ecological relevance 
[80, 84]. In the present work, the nanoformulations did 
not appear to negatively affect swimming performance, 
despite the AChE decrease. On the contrary, the velocity 
and distance covered by the zebrafish larvae increased, 
in a response evoked to assist the fish in escaping from 
predators. Future studies will be needed to further eluci-
date these effects in zebrafish larvae.
Evaluation of zebrafish body weight
The control of fish nutrition is essential in the aquacul-
ture industry, in order to maintain good health, strong 
immune systems, and resistance to disease [85]. The use 
of natural vitamins in aquaculture has been shown to 
provide good growth, satisfactory development, and nor-
mal cell function in aquatic organisms [86].
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Ascorbic acid encapsulated in the CS and PCL nano-
particles was incorporated at different concentra-
tions (25, 50, and 100 mg/kg) in a commercial fish feed 
(TetraMIN). Figure 8A shows the fish sizes obtained for 
the control group (TetraMIN alone) and the nanopar-
ticle groups. The fish in the control group showed an 
average size of 20  mm, while the fish that received the 
commercial feed plus PCL nanoparticles (NPs_PCL_
AA) at different concentrations showed a larger size of 
23 ± 1.1 mm, representing an increase of 15%, compared 
to the control group. Similar results were obtained for the 
fish in the groups that received the commercial feed plus 
CS nanoparticles (NPs_CS_AA) at different concentra-
tions, with an average size of 24 ± 0.8 mm, representing 
an increase of 20%, compared to the control group. The 
results showed that the higher the concentration of AA 
added to the food, the greater the size of the fish. Both 
groups treated with 100 mg/kg showed a significant dif-
ference in relation to the control group and the other 
concentrations, whereas there was no significant differ-
ence in fish size between the NPs_CS_AA and NPs_PCL_
AA groups. These results indicated that neither colloidal 
system affected growth of the fish.
Figure  8B shows the weights of the fish after expo-
sure to the different treatments. An average final weight 
of 60.97  mg was obtained for the control group fed the 
commercial food (TetraMIN). The groups fed the com-
mercial food with the addition of NPs_PCL_AA and 
NPs_CS_AA showed higher weights, compared to the 
control, with the weight increasing as the AA concen-
tration was increased, similar to the effect observed for 
fish length. The final mean weights for the groups fed 25, 
50, and 100 mg  kg−1 of NPs_CS_AA were 117.5 ± 19.10, 
144.5 ± 27.71, and 218.7 ± 48.3  mg, respectively. The 
corresponding values for the NPs_PCL_AA group were 
117.4 ± 17.1, 162.32 ± 21.8, and 223.9 ± 29.55 mg, respec-
tively. These results showed that the AA stimulated the 
development of the fish, with no apparent harm caused 
by the nanocarrier systems.
The effects of AA supplementation on fish growth 
were studied by Nsonga et  al. [87], who quantitatively 
determined the dietary requirement of AA for the tila-
pia species, as well as the effect of this vitamin on fish 
growth. Different concentrations of AA (20, 40, 60, and 
80  mg   kg−1) were tested and it was found that supple-
mentation with AA at 60 mg   kg−1 in the feed increased 
weight gain and maintained good fish health. Supple-
mentation at 80  mg   kg−1 did not significantly increase 
fish development, compared to the 60 mg  kg−1 dosage. In 
the present work, a supplementation dosage of 100 mg/
kg had a greater effect on fish development, compared 
to the lower dosages tested (25 and 50 mg   kg−1). In the 
work of Nsonga et al. [87], it is possible that AA degra-
dation may have occurred, since the vitamin was not 
protected, which contributed to the absence of any differ-
ence between the effects of the dosages of 60 and 80 mg/
kg. In the present case, the AA was protected, enabling it 
to be more effectively directed at the fish, consequently 
resulting in better fish development when increasing 
amounts of AA were added to the feed. In other work, 
supplementation of the fish diet with chitosan nanopar-
ticles had positive effects on body weight, weight gain, 
and specific growth rate of grey mullet (Liza ramada) 
[88]. Similar results were observed for Nile tilapia [84–
86, 89, 90], rainbow trout [91], silver carp [92], and loach 
[93] fed diets enriched with chitosan and/or chitosan 
Fig. 8 Evaluation of body length A and weight B of zebrafish fed different diets. The control group was fed commercial food (TetraMIN), while the 
other groups were fed TetraMIN supplemented with different concentrations (25, 50, and 100 mg/kg) of NPs_CS_AA and NPs_PCL_AA. Statistical 
tests were performed using ANOVA (two-way, significance of p < 0.05) to evaluate differences among the groups, where α, β, and δ indicate 
statistically significant differences from the control, 25 mg/kg, and 50 mg/kg groups, respectively (n = 10)
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nanoparticles. These positive effects of chitosan could 
be attributed to its ability to activate digestive enzymes, 
as well as to inhibit pathogenic bacteria, while activating 
beneficial ones [94].
Although dietary supplementation with micro-scale 
chitosan has shown positive results in the growth of 
some fish species, another study found that supplementa-
tion of the diet with micro-scale chitosan (at 5 g  kg−1) did 
not lead to any significant difference in silver carp growth 
parameters, compared to control groups [92]. On the 
other hand, the authors showed that the animals supplied 
with a diet supplemented with chitosan nanoparticles 
(5 g   kg−1) showed 29% greater weight gain, higher SGR, 
and better FCR, compared to the control and micro-scale 
chitosan groups [92]. These results could be explained by 
the higher absorption and bioavailability of chitosan nan-
oparticles in the fish gastrointestinal tract [95], as well 
as increased residence time of the nanoparticles, which 
increased the contact with the absorptive epithelium, 
consequently directly influencing fish growth [92, 96]. 
Greater growth of fish supplemented with chitosan nano-
particles, compared to those supplemented with micro-
scale chitosan, has been observed for species including 
Oreochromis nicoticus [96, 97] and Clarias gariepinus 
[98]. However, it should be noted that for the same diet 
formulation, there were differences in the weight gains 
of the different species tested, which could have been 
related to the fish growth rate [99].
Conclusions
The results of this work demonstrated that the chi-
tosan and PCL nanocarrier systems could be effectively 
loaded with ascorbic acid. High encapsulation effi-
ciencies were obtained for both systems, with values 
of 96 ± 0.5% for NPs_CS_AA and 91 ± 0.2% for NPs_
PCL_AA, enabling protection of the vitamin against 
degradation. The formulations presented average nano-
particle diameters of 314 ± 3 and 303 ± 1  nm, respec-
tively, and were stable during storage. In  vitro studies 
showed that both systems provided sustained release of 
AA, while oxidation tests showed that the PCL nano-
particles provided longer protection. In toxicity tests, 
the NPs_PCL_AA formulation showed a lower mortal-
ity rate, compared to the chitosan nanoparticles formu-
lation, with  LC50 values of 57.4 and 179.6 mg  mL−1 for 
NPS_CS_AA and NPs_PCL_AA, respectively. Encapsu-
lation of the AA resulted in decreased malformations 
in the zebrafish embryos and larvae, compared to the 
non-encapsulated compound. The larvae exposed to 
AA encapsulated in the chitosan and PCL nanoparticles 
showed dose-dependent increases of speed and dis-
tance traveled. In contrast, most of the groups showed 
significant dose-dependent decreases of AChE activ-
ity, which did not seem sufficient to affect behavior, but 
could have led to morphological changes influenced by 
the cholinergic system, such as curvature of the fish tail. 
The findings showed that the PCL nanoparticles system 
had greater potential to protect ascorbic acid and also 
presented lower toxicity, compared to the chitosan nan-
oparticles system, possibly due to the slower release of 
the active compound from the PCL nanoparticles. The 
results demonstrated that the use of nanotechnology 
can open up new perspectives in aquaculture, helping 
to reduce feed nutrient losses, promoting faster growth 
of fish, and potentially reducing production costs. The 
use of nanotechnology in aquaculture can make an 
important contribution to the sustainable provision of 
healthy products in the food industry. The findings also 
demonstrated the suitability of zebrafish developmental 
parameters for use in environmental risk assessments 
of compounds and nanomaterials.
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